Hikma Pharmaceuticals Plc Director/PDMR Shareholding (5610L)
September 06 2019 - 10:25AM
UK Regulatory
TIDMHIK
RNS Number : 5610L
Hikma Pharmaceuticals Plc
06 September 2019
Notification and public disclosure of transactions by person
discharging managerial responsibilities
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Disposal of 150,000 Ordinary Shares of 10 pence
transaction each in Hikma Pharmaceuticals PLC by Banque
Lombard Odier & Cie SA
c) Price(s) and Price(s): GBP20.56
volume(s) Volume(s): 49,826
Price(s): GBP19.85
Volume(s): 25,000
Price(s): GBP19.82
Volume(s): 25,000
Price(s): GBP19.84
Volume(s): 25,000
Price(s): GBP19.82
Volume(s): 25,174
d) Aggregated information Aggregated volume: 150,000
Price: GBP20.07
Total: GBP3,011,121
e) Date of the transaction 4 and 6 September 2019
f) Place of the London Stock Exchange (XLON)
transaction
Peter Speirs, Company Secretary, Responsible for releasing this
announcement
6 September 2019
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBSGDCXDGBGCL
(END) Dow Jones Newswires
September 06, 2019 10:25 ET (14:25 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2023 to Apr 2024